Buckle Up – Get Ready For A Blood Bath In The Stock Market
Buckle up – it’s a crazy day in the stock market with everything selling off in a big way. The only asset rising in value…
Investing
The Return Of “Stagflation,” The Dirtiest Word In Economics
Today we’re going to talk about one of the dirtiest words in all of finance… And that word is “stagflation.” Stagflation happens when inflation is…
Will Russia/Ukraine Accelerate The Bear Market?
With all the tell-tale signs of a bear market rearing its ugly head, the war between Russia and Ukraine may only hasten the arrival of…
Growth Stocks vs Value Stocks: Which Is Better In The Stock Market Today?
What’s The Difference Between Growth and Value Investing? Growth and value refer to two categories of stocks and the investing styles built on their differences.…
Crypto Secret: Investing Like You’re A Part Of The Club
There’s an old adage about investing: “follow the money.” The ultra-rich are more than just dabbling in cryptocurrency; they’re leading the DeFi charge! “Fake it…
Rocky Markets Call For Stodgy REITs (Like One That Yields 5.6%!)
Yesterday, I wrote that there are no called strikes when investing. There’s no rule that says you have to be fully invested at all times.…
All Psyched Up: A Current List Of Psychedelics Stocks To Watch
When it comes to psychedelics, today’s article notes that “While this industry is still in its early stages, the promising potential of psychedelic medicine drug…
When It Comes To These 2 Biopharma Stocks’ Near-Term Gains, Analysts Are Seeing (More Than) Double!
Today’s article highlights two clinical-stage biopharmaceutical stocks that analysts expect to more than double in the coming months — one engaged in discovering and developing…
These 19 “Moaty” Small-Caps Are High-Quality & Undervalued
Smaller-cap companies have had a good 12 months, and the author of today’s article notes that “the return picture over the trailing three-year period suggests…
Will August Bring FDA Approvals For These Biotech Stocks?
With just a few days remaining in July, the FDA has approved four novel drugs this month, including a treatment for a parasitic “sleeping sickness”…